Journal September 27, 2026 7 min read

How Does Thyroid Function Work? A Research Overview

Thyroid function is a multi-tiered endocrine system. This research overview examines the hypothalamic-pituitary-thyroid axis, thyroid hormone synthesis, and recent studies on thyroid function in various clinical and rese

peptides-pro Editorial

How Does Thyroid Function Work?

Thyroid function refers to the integrated physiological system that produces, regulates, and responds to thyroid hormones, primarily thyroxine (T4) and triiodothyronine (T3). These hormones are synthesized in the thyroid gland, a butterfly-shaped endocrine organ located in the anterior neck, and are critical for regulating basal metabolic rate, growth, development, and numerous other physiological processes. The system operates as a classic negative-feedback loop involving the hypothalamus, pituitary gland, and thyroid gland, collectively known as the hypothalamic-pituitary-thyroid (HPT) axis. The thyroid gland produces predominantly T4, which is converted to the more biologically active T3 in peripheral tissues by deiodinase enzymes. Thyroid hormone secretion is stimulated by thyroid-stimulating hormone (TSH) from the anterior pituitary, which in turn is regulated by thyrotropin-releasing hormone (TRH) from the hypothalamus. Circulating thyroid hormones exert negative feedback on both the hypothalamus and pituitary to maintain stable serum levels. The thyroid gland also produces calcitonin, a hormone involved in calcium homeostasis, though its role in human physiology is less prominent than that of T4 and T3.

The work described in this overview centres on the HPT axis and its interactions with metabolic, inflammatory, and reproductive pathways. Research studies have explored thyroid function in diverse contexts, including autoimmune thyroid disease, obesity, hypothyroidism management, and the effects of other hormonal therapies on thyroid parameters. The following sections summarize findings from recent clinical and observational studies, with attention to the specific populations and models in which effects were observed.

Research Studies

Vitamin E and Oxidative Stress in Levothyroxine-Treated Hypothyroidism

A clinical trial is investigating whether vitamin E supplementation as an adjunct to levothyroxine therapy can reduce oxidative stress, improve antioxidant defence mechanisms, and favourably influence thyroid hormone status in patients with hypothyroidism [1]. The study aims to establish an evidence-based framework for integrating targeted antioxidant therapies into standard hypothyroid management strategies [1]. This research is ongoing and has not yet reported outcomes; the hypothesis is that antioxidant support may address residual oxidative burden in levothyroxine-treated individuals.

Enclomiphene and Cardiovascular Events in a Patient with Prior Mitral Valve Repair

A case report described a 46-year-old man with a history of mitral valve repair and chronic immune thrombocytopenia who developed atrial flutter shortly after inadvertently escalating his enclomiphene citrate dose from 25 mg daily to 50 mg daily [2]. Laboratory evaluation at presentation showed chronic thrombocytopenia with a platelet count of 36 × 10⁹/L, while thyroid function, cardiac biomarkers, and electrolytes were normal [2]. Transthoracic echocardiography revealed preserved left ventricular systolic function with mild aortic regurgitation [2]. The authors noted that enclomiphene citrate is increasingly prescribed off-label for secondary male hypogonadism, and its cardiovascular safety profile remains poorly characterised [2]. This single case does not establish causation but highlights the need for further surveillance.

Long-Acting Growth Hormone Analogs and Hypothalamic-Pituitary Axes in Children

A prospective observational study examined hormonal changes in 33 children with isolated growth hormone deficiency who were either starting long-acting growth hormone (LAGH) somatrogon (n=16) or switching from daily recombinant human growth hormone to the same weekly analogue (n=17) [3]. The study aimed to assess the impact of LAGH on other pituitary axes, including the thyroid axis, which remains unclear [3]. While the full results are not detailed in the available abstract, the investigation underscores the importance of monitoring thyroid function in paediatric patients receiving LAGH therapy.

Biomarkers and Pharmacogenomics for Precision Depression Therapy

A randomized controlled trial is evaluating whether pharmacogenomics-guided therapy improves outcomes in major depressive disorder compared to conventional treatment [4]. The study will enroll 220 patients and includes a matched healthy control cohort for cross-sectional biomarker comparisons [4]. Although thyroid function is not the primary focus, thyroid hormones are known to influence mood and are often assessed in depression research; this trial may provide incidental data on thyroid parameters in this population.

Obesity and Thyroid Function in a Chinese Real-World Registry

A large real-world registry study will enroll 10,000 patients with obesity across approximately 50 medical institutions in China [5]. Baseline assessments include a thyroid function panel comprising three items, alongside demographic, metabolic, and hepatic elasticity measurements [5]. Patients will receive weight-loss therapy in routine clinical practice, and data on adverse events and therapeutic changes will be collected [5]. This registry aims to characterize thyroid function in the context of obesity and weight-loss interventions.

Soluble α-Klotho-FGF23 Axis in Hashimoto's Thyroiditis

A prospective case-control study is comparing serum soluble α-Klotho and fibroblast growth factor 23 (FGF23) levels between adults with Hashimoto's thyroiditis and age- and sex-matched healthy controls [6]. Hashimoto's thyroiditis is the most common autoimmune thyroid disease and is associated with chronic low-grade systemic inflammation beyond thyroid hormone dysfunction [6]. The study will investigate associations between these mineral metabolism markers and thyroid function parameters, inflammatory markers, and other clinical variables [6]. This research may elucidate novel pathways linking thyroid autoimmunity to systemic inflammation and aging-related processes.

Luteinizing Hormone, hCG, and Thyroid Function in Endocrine Disorders

A study is evaluating the role of luteinizing hormone (LH) and human chorionic gonadotropin (hCG) in adult patients undergoing assessment for endocrine disorders [7]. Recent research suggests that LH and hCG may influence bone health, body weight, kidney function, thyroid function, and adrenal gland function, though little is known about these effects [7]. The study focuses on postmenopausal women and older men, populations in which LH levels rise substantially [7]. This investigation may clarify whether these reproductive hormones modulate thyroid activity.

Serum Adipokines and Metabolic Parameters with Hormone Replacement in Hypothyroidism

A prospective observational study is evaluating changes in serum adipokine levels—including asprosin, adipolin, omentin-1, and visfatin—together with metabolic parameters in newly diagnosed primary hypothyroid patients before and after 8 weeks of levothyroxine replacement therapy [8]. Primary hypothyroidism is associated with dyslipidemia, insulin resistance, adipose tissue dysfunction, and altered adipokine secretion [8]. Although levothyroxine effectively restores thyroid hormone levels, the extent to which biochemical recovery reflects metabolic improvement remains unclear [8]. This study may identify adipokine signatures that track with metabolic restoration.

Lateral Neck Lymph Node Dissection and Parathyroid Function in Papillary Thyroid Carcinoma

A retrospective analysis of 347 patients with papillary thyroid carcinoma compared outcomes across three progressively extensive lateral neck dissection schemes to assess the graded effect on parathyroid function [9]. The study found that more extensive dissection was associated with a higher incidence of postoperative hypoparathyroidism, though the abstract does not provide specific numerical data [9]. This finding is relevant to surgical management of thyroid cancer and the risk of parathyroid injury.

Persistent TSH Elevation and Autoimmune Adrenal Insufficiency in an Adolescent

A case report described an adolescent with autoimmune thyroiditis who had persistent elevation of thyroid-stimulating hormone despite levothyroxine therapy, which ultimately revealed autoimmune adrenal insufficiency [10]. The authors noted that patients with autoimmune thyroiditis are at increased risk for other autoimmune conditions, including autoimmune adrenal insufficiency, but routine screening is not recommended [10]. This case highlights the potential for concurrent endocrinopathies and the need for clinical vigilance when TSH remains elevated despite adequate replacement.

Goserelin vs. Leuprolide in Premenopausal Breast Cancer Patients

A retrospective cohort study compared the efficacy and safety of goserelin and leuprolide, two gonadotropin-releasing hormone (GnRH) agonists used for ovarian function suppression in premenopausal breast cancer patients receiving adjuvant endocrine therapy [11]. The study aimed to determine whether different molecular structures lead to clinically meaningful differences in outcomes [11]. While thyroid function was not the primary endpoint, GnRH agonists can influence the HPT axis indirectly, and this study may provide relevant safety data.

Circulating Omentin-1 and HMGB1 in Hashimoto Thyroiditis

A study evaluated circulating levels of omentin-1, an anti-inflammatory adipokine, and high-mobility group box 1 (HMGB1), an inflammatory alarmin, in patients with Hashimoto thyroiditis [12]. Hashimoto thyroiditis is a chronic autoimmune disease that extends beyond abnormalities in thyroid hormone levels [12]. The findings may link adipokine dysregulation and inflammation to thyroid autoimmunity, though specific results are not detailed in the available abstract [12].

If you are reading this for personal health reasons

The materials and information discussed here are provided for laboratory research purposes only. We do not provide dosing, medical guidance, or recommendations for personal use. Anyone considering a compound or therapy for themselves should consult a licensed clinician.